Trial Outcomes & Findings for mHealth for Breast Cancer Survivors With Insomnia (NCT NCT05233800)
NCT ID: NCT05233800
Last Updated: 2025-01-24
Results Overview
Data will be collected on the Insomnia Severity Index (ISI) total score pre- and post-intervention as our primary outcome. The ISI is a seven-item questionnaire with response categories from 0-4 (total score 0-28) asking about sleep patterns and specifically characterizing insomnia over the two weeks prior. The ISI defines 'no clinically significant' insomnia as a score of 0-7, 'sub-threshold' insomnia as a score of 8-14, 'moderate severity clinical' insomnia' a scores of 15-21, and 'severe clinical' insomnia as a score of 22-28. Clinically relevant target for success is to achieve sub-threshold or better scores (≤14) among \>80% of the intervention participants
COMPLETED
NA
76 participants
6 weeks
2025-01-24
Participant Flow
Participant milestones
| Measure |
Voice-Activated Smart Speaker Program
Faster Asleep
Faster Asleep Smart Speaker Program: Participants will receive a smart speaker device with a pre-loaded Faster Asleep program. Participants will be asked to engage with the program daily, either using the voice-activated speakers or an accompanying smart-phone app. The study duration is six-weeks and is completed individually using fully automated interaction to deliver components of cognitive behavioral therapy for insomnia.
|
Website
Faster Asleep Website
Faster Asleep Website: Controls will have access to a website with information about CBT-I and breast cancer survivorship and will be told to engage with the website as desired. The content will be drawn from the education script that is programmed into the phone app accompanying the smart speaker program.
|
|---|---|---|
|
Overall Study
STARTED
|
38
|
38
|
|
Overall Study
COMPLETED
|
35
|
35
|
|
Overall Study
NOT COMPLETED
|
3
|
3
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
mHealth for Breast Cancer Survivors With Insomnia
Baseline characteristics by cohort
| Measure |
Voice-Activated Smart Speaker Program
n=38 Participants
Faster Asleep
Faster Asleep Smart Speaker Program: Participants will receive a smart speaker device with a pre-loaded Faster Asleep program. Participants will be asked to engage with the program daily, either using the voice-activated speakers or an accompanying smart-phone app. The study duration is six-weeks and is completed individually using fully automated interaction to deliver components of cognitive behavioral therapy for insomnia.
|
Website
n=38 Participants
Faster Asleep Website
Faster Asleep Website: Controls will have access to a website with information about CBT-I and breast cancer survivorship and will be told to engage with the website as desired. The content will be drawn from the education script that is programmed into the phone app accompanying the smart speaker program.
|
Total
n=76 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
62.6 years
STANDARD_DEVIATION 9.8 • n=5 Participants
|
59.8 years
STANDARD_DEVIATION 8.7 • n=7 Participants
|
61.2 years
STANDARD_DEVIATION 9.3 • n=5 Participants
|
|
Sex: Female, Male
Female
|
38 Participants
n=5 Participants
|
38 Participants
n=7 Participants
|
76 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
2 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
36 Participants
n=5 Participants
|
38 Participants
n=7 Participants
|
74 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
7 Participants
n=5 Participants
|
9 Participants
n=7 Participants
|
16 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
28 Participants
n=5 Participants
|
25 Participants
n=7 Participants
|
53 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
2 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
38 participants
n=5 Participants
|
38 participants
n=7 Participants
|
76 participants
n=5 Participants
|
|
Marital status
Single
|
6 Participants
n=5 Participants
|
7 Participants
n=7 Participants
|
13 Participants
n=5 Participants
|
|
Marital status
Married or partnered
|
25 Participants
n=5 Participants
|
24 Participants
n=7 Participants
|
49 Participants
n=5 Participants
|
|
Marital status
Divorced or separated
|
5 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
10 Participants
n=5 Participants
|
|
Marital status
Widowed
|
2 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Employment
Full Time
|
13 Participants
n=5 Participants
|
16 Participants
n=7 Participants
|
29 Participants
n=5 Participants
|
|
Employment
Part time
|
4 Participants
n=5 Participants
|
7 Participants
n=7 Participants
|
11 Participants
n=5 Participants
|
|
Employment
Retired
|
16 Participants
n=5 Participants
|
15 Participants
n=7 Participants
|
31 Participants
n=5 Participants
|
|
Employment
Unemployed
|
5 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
5 Participants
n=5 Participants
|
|
Education
High school/GED/Some college
|
6 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
10 Participants
n=5 Participants
|
|
Education
College Degree
|
14 Participants
n=5 Participants
|
16 Participants
n=7 Participants
|
30 Participants
n=5 Participants
|
|
Education
Graduate Degree
|
18 Participants
n=5 Participants
|
18 Participants
n=7 Participants
|
36 Participants
n=5 Participants
|
|
TNM Cancer Stage at diagnosis
Stage 0
|
0 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
TNM Cancer Stage at diagnosis
Stage 1
|
21 Participants
n=5 Participants
|
12 Participants
n=7 Participants
|
33 Participants
n=5 Participants
|
|
TNM Cancer Stage at diagnosis
Stage 2
|
12 Participants
n=5 Participants
|
17 Participants
n=7 Participants
|
29 Participants
n=5 Participants
|
|
TNM Cancer Stage at diagnosis
Stage 3
|
3 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
8 Participants
n=5 Participants
|
|
TNM Cancer Stage at diagnosis
Stage 4
|
2 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
BMI
|
25.9 kg/m2
n=5 Participants
|
25.6 kg/m2
n=7 Participants
|
25.8 kg/m2
n=5 Participants
|
PRIMARY outcome
Timeframe: 6 weeksPopulation: Intent to treat
Data will be collected on the Insomnia Severity Index (ISI) total score pre- and post-intervention as our primary outcome. The ISI is a seven-item questionnaire with response categories from 0-4 (total score 0-28) asking about sleep patterns and specifically characterizing insomnia over the two weeks prior. The ISI defines 'no clinically significant' insomnia as a score of 0-7, 'sub-threshold' insomnia as a score of 8-14, 'moderate severity clinical' insomnia' a scores of 15-21, and 'severe clinical' insomnia as a score of 22-28. Clinically relevant target for success is to achieve sub-threshold or better scores (≤14) among \>80% of the intervention participants
Outcome measures
| Measure |
Voice-Activated Smart Speaker Program
n=35 Participants
Faster Asleep
Faster Asleep Smart Speaker Program: Participants will receive a smart speaker device with a pre-loaded Faster Asleep program. Participants will be asked to engage with the program daily, either using the voice-activated speakers or an accompanying smart-phone app. The study duration is six-weeks and is completed individually using fully automated interaction to deliver components of cognitive behavioral therapy for insomnia.
|
Website
n=35 Participants
Faster Asleep Website
Faster Asleep Website: Controls will have access to a website with information about CBT-I and breast cancer survivorship and will be told to engage with the website as desired. The content will be drawn from the education script that is programmed into the phone app accompanying the smart speaker program.
|
|---|---|---|
|
Insomnia Symptoms
|
-8.4 units on a scale
Standard Deviation 4.7
|
-2.6 units on a scale
Standard Deviation 3.5
|
SECONDARY outcome
Timeframe: 6 weeksPopulation: Intent to treat
Sleep efficiency is calculated by the total time sleeping over the total time in bed.
Outcome measures
| Measure |
Voice-Activated Smart Speaker Program
n=35 Participants
Faster Asleep
Faster Asleep Smart Speaker Program: Participants will receive a smart speaker device with a pre-loaded Faster Asleep program. Participants will be asked to engage with the program daily, either using the voice-activated speakers or an accompanying smart-phone app. The study duration is six-weeks and is completed individually using fully automated interaction to deliver components of cognitive behavioral therapy for insomnia.
|
Website
n=35 Participants
Faster Asleep Website
Faster Asleep Website: Controls will have access to a website with information about CBT-I and breast cancer survivorship and will be told to engage with the website as desired. The content will be drawn from the education script that is programmed into the phone app accompanying the smart speaker program.
|
|---|---|---|
|
Six Week Change in Sleep Efficiency
|
0.09 proportion of time asleep/time in bed
Interval 0.07 to 0.11
|
0.05 proportion of time asleep/time in bed
Interval 0.03 to 0.07
|
SECONDARY outcome
Timeframe: 6 weeksPopulation: Intent to treat
Amount of time awake during the night
Outcome measures
| Measure |
Voice-Activated Smart Speaker Program
n=35 Participants
Faster Asleep
Faster Asleep Smart Speaker Program: Participants will receive a smart speaker device with a pre-loaded Faster Asleep program. Participants will be asked to engage with the program daily, either using the voice-activated speakers or an accompanying smart-phone app. The study duration is six-weeks and is completed individually using fully automated interaction to deliver components of cognitive behavioral therapy for insomnia.
|
Website
n=35 Participants
Faster Asleep Website
Faster Asleep Website: Controls will have access to a website with information about CBT-I and breast cancer survivorship and will be told to engage with the website as desired. The content will be drawn from the education script that is programmed into the phone app accompanying the smart speaker program.
|
|---|---|---|
|
Six Week Change in Wake After Sleep Onset
|
-18.6 minutes
Interval -23.9 to -13.36
|
-9.1 minutes
Interval -14.6 to -3.63
|
SECONDARY outcome
Timeframe: 6 weeksPopulation: Intent to treat
Time to fall asleep
Outcome measures
| Measure |
Voice-Activated Smart Speaker Program
n=35 Participants
Faster Asleep
Faster Asleep Smart Speaker Program: Participants will receive a smart speaker device with a pre-loaded Faster Asleep program. Participants will be asked to engage with the program daily, either using the voice-activated speakers or an accompanying smart-phone app. The study duration is six-weeks and is completed individually using fully automated interaction to deliver components of cognitive behavioral therapy for insomnia.
|
Website
n=35 Participants
Faster Asleep Website
Faster Asleep Website: Controls will have access to a website with information about CBT-I and breast cancer survivorship and will be told to engage with the website as desired. The content will be drawn from the education script that is programmed into the phone app accompanying the smart speaker program.
|
|---|---|---|
|
Six Week Change in Sleep Onset Latency
|
-13.79 minutes
Interval -18.2 to -9.33
|
-5.46 minutes
Interval -10.1 to -0.86
|
SECONDARY outcome
Timeframe: 6 weeksPopulation: Intent to treat
Total time asleep
Outcome measures
| Measure |
Voice-Activated Smart Speaker Program
n=35 Participants
Faster Asleep
Faster Asleep Smart Speaker Program: Participants will receive a smart speaker device with a pre-loaded Faster Asleep program. Participants will be asked to engage with the program daily, either using the voice-activated speakers or an accompanying smart-phone app. The study duration is six-weeks and is completed individually using fully automated interaction to deliver components of cognitive behavioral therapy for insomnia.
|
Website
n=35 Participants
Faster Asleep Website
Faster Asleep Website: Controls will have access to a website with information about CBT-I and breast cancer survivorship and will be told to engage with the website as desired. The content will be drawn from the education script that is programmed into the phone app accompanying the smart speaker program.
|
|---|---|---|
|
Six Week Change in Total Sleep Time
|
0.26 hours
Interval 0.06 to 0.45
|
0.27 hours
Interval 0.06 to 0.47
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 6 weeksPopulation: intent to treat
A 10-item scale on general usability of technology. This provides a score of 0-100, with above 68 indicating better than average usability, where higher is better. This is a normalized score and not a percentage.
Outcome measures
| Measure |
Voice-Activated Smart Speaker Program
n=35 Participants
Faster Asleep
Faster Asleep Smart Speaker Program: Participants will receive a smart speaker device with a pre-loaded Faster Asleep program. Participants will be asked to engage with the program daily, either using the voice-activated speakers or an accompanying smart-phone app. The study duration is six-weeks and is completed individually using fully automated interaction to deliver components of cognitive behavioral therapy for insomnia.
|
Website
n=35 Participants
Faster Asleep Website
Faster Asleep Website: Controls will have access to a website with information about CBT-I and breast cancer survivorship and will be told to engage with the website as desired. The content will be drawn from the education script that is programmed into the phone app accompanying the smart speaker program.
|
|---|---|---|
|
System Usability Scale
|
72.2 score on a scale
Standard Deviation 16.6
|
50.79 score on a scale
Standard Deviation 15.9
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 6 weeksPopulation: Intent to treat
5-item Likert scale from Very Poor (5) to Very Good (1).
Outcome measures
| Measure |
Voice-Activated Smart Speaker Program
n=35 Participants
Faster Asleep
Faster Asleep Smart Speaker Program: Participants will receive a smart speaker device with a pre-loaded Faster Asleep program. Participants will be asked to engage with the program daily, either using the voice-activated speakers or an accompanying smart-phone app. The study duration is six-weeks and is completed individually using fully automated interaction to deliver components of cognitive behavioral therapy for insomnia.
|
Website
n=35 Participants
Faster Asleep Website
Faster Asleep Website: Controls will have access to a website with information about CBT-I and breast cancer survivorship and will be told to engage with the website as desired. The content will be drawn from the education script that is programmed into the phone app accompanying the smart speaker program.
|
|---|---|---|
|
End of Study Self-reported Sleep Quality
|
2.44 score on a scale
Standard Deviation 0.08
|
3.03 score on a scale
Standard Deviation 0.08
|
Adverse Events
Voice-Activated Smart Speaker Program
Website
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Hannah Arem, Scientific Director, Implementation Science
MedStar Health Research Institute
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place